Home › Free Stock Grades › HYPR
Hyperfine, Inc. (HYPR) Stock Grade
HYPR · Healthcare
A+
Market Cap
$92.3M
P/E Ratio
—
Revenue Growth (YoY)
+5.2%
Net Margin
-262.3%
Return on Equity
—
Dividend Yield
None
About Hyperfine, Inc.'s fundamentals
Hyperfine is a medical specialty company with a market capitalization of $92.3 million that generated 5.2% year-over-year revenue growth. However, the company is currently unprofitable, reporting a negative net margin of -262.3% and a net loss in its latest annual statement, indicating it is spending significantly more than it generates in revenue. The company does not pay a dividend and lacks positive equity returns at this stage of its financial development.